(Q81570219)
Statements
Phase II trial of weekly paclitaxel (80 mg/m2) in platinum and paclitaxel-resistant ovarian and primary peritoneal cancers: a Gynecologic Oncology Group study (English)
Gynecologic Oncology Group
Maurie Markman
John Blessing
Stephen C Rubin
Joseph Connor
Parviz Hanjani
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference